Invariant phenotype and molecular association of biallelic TET2 mutant myeloid neoplasia.

作者: Hassan Awada , Yasunobu Nagata , Abhinav Goyal , Mohammad F. Asad , Bhumika Patel

DOI: 10.1182/BLOODADVANCES.2018024216

关键词:

摘要: Somatic TET2 mutations ( MT ) are frequent in myeloid neoplasia (MN), particularly chronic myelomonocytic leukemia (CMML). includes mostly loss-of-function/hypomorphic hits. Impaired activity skews differentiation of hematopoietic stem cells toward proliferating precursors. This study was prompted by the observation biallelic gene inactivations biTET2 i CMML. We speculated that might be associated with distinct clinicohematological features. analyzed 1045 patients MN. Of 82 cases, 66 were , 13 hemizygous and 3 homozygous (uniparental disomy); remaining (denoted − hereafter) either monoallelic (n = 96) or wild-type 823). Truncation found 83% vs 65% cases P .02). hits founder lesions 72% 38% significantly concurrent included SRSF2 (33%; KRAS / NRAS (16%; .03) as compared . When first hit ancestral most common subsequent affected a second followed ASXL1 RAS DNMT3A BiTET2 without any monocytosis showed an absence S RSF2 older had monocytosis, CMML, normal karyotypes, lower-risk disease patients. Hence, while occurred frequently, did not portend faster progression but rather determined monocytic differentiation, consistent its prevalence Additionally, lower odds cytopenias marrow blasts (≥5%) higher dysplasia hypercellularity. Thus, represent auxiliary assessment tool

参考文章(50)
H Szpurka, L P Gondek, S R Mohan, E D Hsi, K S Theil, J P Maciejewski, UPD1p indicates the presence of MPL W515L mutation in RARS-T, a mechanism analogous to UPD9p and JAK2 V617F mutation. Leukemia. ,vol. 23, pp. 610- 614 ,(2009) , 10.1038/LEU.2008.249
Leila Noetzli, Richard W Lo, Alisa B Lee-Sherick, Michael Callaghan, Patrizia Noris, Anna Savoia, Madhvi Rajpurkar, Kenneth Jones, Katherine Gowan, Carlo L Balduini, Alessandro Pecci, Chiara Gnan, Daniela De Rocco, Michael Doubek, Ling Li, Lily Lu, Richard Leung, Carolina Landolt-Marticorena, Stephen Hunger, Paula Heller, Arthur Gutierrez-Hartmann, Liang Xiayuan, Fred G Pluthero, Jesse W Rowley, Andrew S Weyrich, Walter H A Kahr, Christopher C Porter, Jorge Di Paola, Germline mutations in ETV6 are associated with thrombocytopenia, red cell macrocytosis and predisposition to lymphoblastic leukemia Nature Genetics. ,vol. 47, pp. 535- 538 ,(2015) , 10.1038/NG.3253
Zhe Li, Xiaoqiang Cai, Chen-Leng Cai, Jiapeng Wang, Wenyong Zhang, Bruce E. Petersen, Feng-Chun Yang, Mingjiang Xu, Deletion of Tet2 in mice leads to dysregulated hematopoietic stem cells and subsequent development of myeloid malignancies. Blood. ,vol. 118, pp. 4509- 4518 ,(2011) , 10.1182/BLOOD-2010-12-325241
Luca Malcovati, Matteo G Della Porta, Daniela Pietra, Emanuela Boveri, Andrea Pellagatti, Anna Gallì, Erica Travaglino, Angela Brisci, Elisa Rumi, Francesco Passamonti, Rosangela Invernizzi, Laura Cremonesi, Jacqueline Boultwood, James S Wainscoat, Eva Hellström-Lindberg, Mario Cazzola, None, Molecular and clinical features of refractory anemia with ringed sideroblasts associated with marked thrombocytosis. Blood. ,vol. 114, pp. 3538- 3545 ,(2009) , 10.1182/BLOOD-2009-05-222331
Mingchao Xie, Charles Lu, Jiayin Wang, Michael D McLellan, Kimberly J Johnson, Michael C Wendl, Joshua F McMichael, Heather K Schmidt, Venkata Yellapantula, Christopher A Miller, Bradley A Ozenberger, John S Welch, Daniel C Link, Matthew J Walter, Elaine R Mardis, John F Dipersio, Feng Chen, Richard K Wilson, Timothy J Ley, Li Ding, Age-related mutations associated with clonal hematopoietic expansion and malignancies Nature Medicine. ,vol. 20, pp. 1472- 1478 ,(2014) , 10.1038/NM.3733
Elli Papaemmanuil, Moritz Gerstung, Luca Malcovati, Sudhir Tauro, Gunes Gundem, Peter Van Loo, Chris J Yoon, Peter Ellis, David C Wedge, Andrea Pellagatti, Adam Shlien, Michael John Groves, Simon A Forbes, Keiran Raine, Jon Hinton, Laura J Mudie, Stuart McLaren, Claire Hardy, Calli Latimer, Matteo G Della Porta, Sarah O’Meara, Ilaria Ambaglio, Anna Galli, Adam P Butler, Gunilla Walldin, Jon W Teague, Lynn Quek, Alex Sternberg, Carlo Gambacorti-Passerini, Nicholas CP Cross, Anthony R Green, Jacqueline Boultwood, Paresh Vyas, Eva Hellstrom-Lindberg, David Bowen, Mario Cazzola, Michael R Stratton, Peter J Campbell, None, Clinical and biological implications of driver mutations in myelodysplastic syndromes. Blood. ,vol. 122, pp. 3616- 3627 ,(2013) , 10.1182/BLOOD-2013-08-518886
Lambert Busque, Jay P Patel, Maria E Figueroa, Aparna Vasanthakumar, Sylvie Provost, Zineb Hamilou, Luigina Mollica, Juan Li, Agnes Viale, Adriana Heguy, Maryam Hassimi, Nicholas Socci, Parva K Bhatt, Mithat Gonen, Christopher E Mason, Ari Melnick, Lucy A Godley, Cameron W Brennan, Omar Abdel-Wahab, Ross L Levine, Recurrent somatic TET2 mutations in normal elderly individuals with clonal hematopoiesis Nature Genetics. ,vol. 44, pp. 1179- 1181 ,(2012) , 10.1038/NG.2413
Olivier Kosmider, Véronique Gelsi-Boyer, Meyling Cheok, Sophie Grabar, Véronique Della-Valle, Françoise Picard, Franck Viguié, Bruno Quesnel, Odile Beyne-Rauzy, Eric Solary, Norbert Vey, Mathilde Hunault-Berger, Pierre Fenaux, Véronique Mansat-De Mas, Eric Delabesse, Philippe Guardiola, Catherine Lacombe, William Vainchenker, Claude Preudhomme, François Dreyfus, Olivier A. Bernard, Daniel Birnbaum, Michaëla Fontenay, , TET2 mutation is an independent favorable prognostic factor in myelodysplastic syndromes (MDSs). Blood. ,vol. 114, pp. 3285- 3291 ,(2009) , 10.1182/BLOOD-2009-04-215814
Go Yamamoto, Yasuhito Nannya, Motohiro Kato, Masashi Sanada, Ross L. Levine, Norihiko Kawamata, Akira Hangaishi, Mineo Kurokawa, Shigeru Chiba, D. Gary Gilliland, H. Phillip Koeffler, Seishi Ogawa, Highly Sensitive Method for Genomewide Detection of Allelic Composition in Nonpaired, Primary Tumor Specimens by Use of Affymetrix Single-Nucleotide–Polymorphism Genotyping Microarrays American Journal of Human Genetics. ,vol. 81, pp. 114- 126 ,(2007) , 10.1086/518809